Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MESALAMINE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE DELAYED-RELEASE CAPSULES. MESALAMINE delayed-release capsules, for oral use Initial U.S. Approval: 1987
Medication labelWhy this: Advisory · dailymed-prescription
Mesalamine delayed-release capsules are indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Mesalamine delayed-release capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
- generic_name
- mesalamine
- product_names
- Mesalamine
- ndc
- 60687-556, 0093-5907, 60687-556-33, 60687-556-32
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en